Tectonic Therapeutic, Inc.
TECXHealthcare|Biotechnology|US
$20.64
+1.22 (+6.28%)
DCF Value
$13.73
Tangible Book / Share
$11.64
Cash / Share
$11.91
Clinical Trials (3)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07473700 Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease | Hypertension, Pulmonary, Lung Diseases, Interstitial | P2 | Recruiting | 25 | Open-label | TX000045 |
| NCT06616974 A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) | Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction | P2 | Active | 191 | RCT, Double-blind | TX000045- Dose A, TX000045- Dose B, Placebo |
| NCT07863609 Phase 1b Study of TX002100 in Participants With Hematologic Support-Dependent Hereditary Hemorrhagic Telangiectasia (HHT) | Hereditary Hemorrhagic Telangiectasia (HHT) | P1 | Not Yet Recruiting | 20 | Open-label | TX002100 |